|
Press Releases |
|
 |
|
Wednesday, March 23, 2022 |
|
Alset International Ltd establishes Alset Mining Pte Ltd to embark on cryptocurrency mining activities |
Singapore Exchange-listed Alset International Ltd (SGX Stock Code: 40V) ("Alset", the "Company" or together with its subsidiaries, the "Group) wishes to announce that the Company has plans to embark on cryptocurrency mining business through its subsidiary Alset Mining Pte. Ltd. ("Alset Mining"). more info >> |
|
Monday, February 21, 2022 |
|
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option |
Alset Capital Acquisition Corp. (the "Company") announced on February 3, 2022 the closing of its initial public offering of 7,500,000 units at $10.00 per unit (the "Offering"). more info >> |
|
Monday, October 5, 2020 |
|
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc. |
Document Security Systems, Inc. today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical") has formed a new wholly owned subsidiary, Innate Immune, Inc. ("Innate Immune"), to initiate efficacy testing of a pancoronavirus vaccine, a special type of vaccine designed to protect against multiple coronaviruses. more info >> |
|
Friday, September 18, 2020 |
|
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance |
Document Security Systems, Inc. (NYSE American: DSS) today announced its wholly owned subsidiary Impact BioMedical, Inc., through its subsidiary Global BioLife, Inc., completed efficacy testing of its proprietary 3F Antiviral Biofragrance at a biosafety level 3 containment facility at an independent university. more info >> |
|
Friday, July 31, 2020 |
|
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. more info >> |
|
Wednesday, June 24, 2020 |
|
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that they proved in vitro success of Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. more info >> |
|
Wednesday, June 17, 2020 |
|
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global Research and Discovery Group Sciences ("GRDG"), conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc. ("Vilotos"), was published in the peer-reviewed scientific journal Molecules on June 11, 2020. more info >> |
|
Monday, June 1, 2020 |
|
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc., would like to update its stakeholders on its suite of antiviral and medical technologies. more info >> |
|
Friday, April 24, 2020 |
|
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts |
SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their suite of antiviral and medical technologies, co-owned with its partners, is valued at USD 592 Million (SGD 841 Million). Impact Biomedical's effective ownership of 64.53% in the suite of technologies equates to a value of USD 382 Million (SGD 542 Million). more info >> |
|
Wednesday, March 18, 2020 |
|
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak |
Singapore Exchange-listed Singapore eDevelopment Limited has announced that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. ("GRDG"), recently conducted molecular docking studies, utilizing advanced computational models, which indicate Linebacker and Equivir successfully inhibit infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
三菱重工業、モロッコからJAC形ガスタービン2台を初受注
Feb 12, 2025 14:30: JST
|
|
|
三菱重工業、広島高速交通にアストラムライン向け新型車両7000系AGTの最終編成分を納入
Feb 12, 2025 14:30: JST
|
|
|
MHI Delivers Final 7000-Series AGT Trainset for the Astram Line
Feb 12, 2025 12:24 JST
|
|
|
富士通と横浜国立大学、スーパーコンピュータ「富岳」を利用して、台風に伴う竜巻の予測を可能にする気象シミュレーションを世界で初めて実現
Feb 12, 2025 11:20: JST
|
|
|
China Gas Accelerates Intelligent Transformation
Feb 12, 2025 11:05 HKT/SGT
|
|
|
CGFNS International 報告指出 2024 年赴美護理移民率仍較高
Feb 12, 2025 11:00 HKT/SGT
|
|
|
CGFNS International 报告称 2024 年赴美护士移民率仍然较高
Feb 12, 2025 11:00 HKT/SGT
|
|
|
Fujitsu and Yokohama National University achieve world's first real-time prediction of tornadoes associated with typhoons using supercomputer Fugaku
Feb 12, 2025 11:37 JST
|
|
|
foundit Insights Tracker: Malaysia and Philippines Thrive with 85% and 75% Retail Hiring Growth, Singapore Steadies Ahead
Feb 12, 2025 10:10 HKT/SGT
|
|
|
CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024
Feb 12, 2025 08:00 HKT/SGT
|
|
|
OAP2025 Focus on Southeast Asia's Energy Future
Feb 12, 2025 08:00 HKT/SGT
|
|
|
Naoris Protocol Unveils World's First Post-Quantum DePIN Testnet with Over 2.5 Million Transactions in First Week
Feb 12, 2025 01:00 HKT/SGT
|
|
|
Maharashtra gets Major Economic Boost as CIDCO Signs Landmark MoUs at World Economic Forum, DAVOS
Feb 12, 2025 00:00: JST
|
|
|
Maharashtra gets Major Economic Boost as CIDCO Signs Landmark MoUs at World Economic Forum, DAVOS
Feb 11, 2025 23:00 HKT/SGT
|
|
|
香港股票分析師協會與「百本醫護控股有限公司」附屬公司簽署合作備忘錄
Feb 11, 2025 21:21 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|